Saturday, May 02, 2026

In Detail Full day, Saturday, May 02, 2026, Timezone: America/Chicago

6 Things to Know About Medtronic’s Cyberattack

Katie Adams / medcitynews - Medtronic suffered a cyberattack on its corporate IT systems. The incident highlights growing cybersecurity risks in the medtech sector, with cybergangs increasingly using phishing and other human-engineering tactics to gain access to data.The post 6 Thin…

AI Summary: Medtronic reported an IT systems breach following a cyberattack, prompting an internal probe and operational mitigation efforts. The company is assessing clinical and supply impacts, notifying stakeholders, and coordinating with cybersecurity authorities — a reminder that even medtech giants are not immune to the digital snarls that can ripple through patient care and profits.

Runners have finally completed a sub 2-hour marathon, but another running world record was recently smashed — this time by a humanoid robot. Here's how.

livescience - The D1 humanoid robot, built by a smartphone manufacturer, has beaten the human-held world record by around seven minutes.

AI Summary: Two elite athletes have crossed a long-standing human performance line by completing a marathon in under two hours, a landmark moment for endurance sport. The achievement rewrites expectations, prompts fresh debate about pacing and conditions, and hands scientists and coaches new data to dissect — plus the inevitable breathless headlines and humblebragging training plans to follow.

Avalyn Pharma Takes a Breath to Raise $300M in IPO Cash for Lung Drug Trials

Frank Vinluan / medcitynews - Avalayn Pharma found strong investor interest in its inhalable drugs in development for two types of pulmonary fibrosis, enabling the company to upsize its IPO. Data from two mid-stage studies are expected in 2027. The post Avalyn Pharma Takes a Breath to…

AI Summary: Avalyn Pharma has substantially increased its IPO, targeting roughly $300 million to bankroll late-stage trials of its respiratory drug candidate. The move reflects strong investor enthusiasm for lung‑disease therapeutics and gives the company a bigger war chest to advance programs previously dependent on venture capital and partnerships.

AI, face photos may predict cancer survival: Mass General Brigham study

Giles Bruce / beckershospitalreview - Using multiple photos from across a patient’s course of treatment in the FaceAge AI tool may be an even better predictor of survival than a single photo alone, a new Mass General Brigham study found. Researchers behind FaceAge, which uses AI to analyze a …

AI Summary: An AI model trained on clinical cohorts at Mass General Brigham can estimate biological aging from simple facial photos and links accelerated facial aging to poorer cancer survival. The research suggests noninvasive image-based signals could complement standard prognostic markers, offering a surprising, low-cost way to flag higher-risk patients earlier.